Vanda Pharmaceuticals Inc (VNDA)
4.94
+0.04
(+0.82%)
USD |
NASDAQ |
Nov 21, 16:00
4.935
0.00 (0.00%)
Pre-Market: 20:00
Vanda Pharmaceuticals Shareholders Equity (Quarterly): 541.22M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 541.22M |
June 30, 2024 | 542.52M |
March 31, 2024 | 544.00M |
December 31, 2023 | 544.91M |
September 30, 2023 | 543.10M |
June 30, 2023 | 539.90M |
March 31, 2023 | 535.74M |
December 31, 2022 | 527.20M |
September 30, 2022 | 515.66M |
June 30, 2022 | 508.55M |
March 31, 2022 | 502.12M |
December 31, 2021 | 504.93M |
September 30, 2021 | 493.32M |
June 30, 2021 | 481.22M |
March 31, 2021 | 467.63M |
December 31, 2020 | 453.27M |
September 30, 2020 | 440.57M |
June 30, 2020 | 431.58M |
March 31, 2020 | 416.39M |
December 31, 2019 | 410.94M |
September 30, 2019 | 400.91M |
June 30, 2019 | 296.69M |
March 31, 2019 | 278.40M |
December 31, 2018 | 275.42M |
September 30, 2018 | 261.42M |
Date | Value |
---|---|
June 30, 2018 | 251.27M |
March 31, 2018 | 241.14M |
December 31, 2017 | 131.39M |
September 30, 2017 | 130.47M |
June 30, 2017 | 131.42M |
March 31, 2017 | 128.14M |
December 31, 2016 | 131.33M |
September 30, 2016 | 129.16M |
June 30, 2016 | 121.61M |
March 31, 2016 | 123.01M |
December 31, 2015 | 133.03M |
September 30, 2015 | 145.94M |
June 30, 2015 | 149.75M |
March 31, 2015 | 152.47M |
December 31, 2014 | 160.82M |
September 30, 2014 | 1.063M |
June 30, 2014 | 0.885M |
March 31, 2014 | 20.98M |
December 31, 2013 | 44.12M |
September 30, 2013 | 50.00M |
June 30, 2013 | 5.026M |
March 31, 2013 | 6.481M |
December 31, 2012 | 9.905M |
September 30, 2012 | 15.35M |
June 30, 2012 | 20.08M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
410.94M
Minimum
Dec 2019
544.91M
Maximum
Dec 2023
497.24M
Average
506.74M
Median
Shareholders Equity (Quarterly) Benchmarks
Zevra Therapeutics Inc | 69.77M |
Black Diamond Therapeutics Inc | 97.43M |
Edgewise Therapeutics Inc | 488.88M |
NovaBay Pharmaceuticals Inc | 1.072M |
Palatin Technologies Inc | -7.686M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 645.12M |
Total Liabilities (Quarterly) | 103.89M |
Current Ratio | 4.853 |